Lenalidomide enhances the function of CS1 chimeric antigen receptor redirected T cells against multiple myeloma

PURPOSE: Multiple myeloma (MM) remains an incurable malignancy of plasma cells despite considerable advances in treatment. The purpose of the study was to develop novel CARs for the treatment of MM and explore combinatorial therapy using CAR T cells and immunomodulatory drugs such as lenalidomide fo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cancer Res
Autori principali: Wang, Xiuli, Walter, Miriam, Urak, Ryan, Weng, Lihong, Huynh, Christian, Lim, Laura, Wong, ChingLam W., Chang, Wen-Chung, Thomas, Sandra, Sanchez, James F., Yang, Lu, Brown, Christine E., Pichiorri, Flavia, Htut, Myo, Krishnan, Amrita, Forman, Stephen J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5991104/
https://ncbi.nlm.nih.gov/pubmed/29061640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-0344
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi